Trexquant Investment’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.3M | Sell |
104,438
-9,290
| -8% | -$294K | 0.04% | 700 |
|
2025
Q1 | $3.77M | Sell |
113,728
-61,846
| -35% | -$2.05M | 0.04% | 617 |
|
2024
Q4 | $6.04M | Buy |
+175,574
| New | +$6.04M | 0.07% | 453 |
|
2023
Q3 | – | Sell |
-57,468
| Closed | -$2.02M | – | 1611 |
|
2023
Q2 | $2.02M | Buy |
57,468
+42,259
| +278% | +$1.49M | 0.05% | 488 |
|
2023
Q1 | $497K | Sell |
15,209
-18,052
| -54% | -$589K | 0.01% | 1005 |
|
2022
Q4 | $1.83M | Buy |
33,261
+24,047
| +261% | +$1.32M | 0.05% | 432 |
|
2022
Q3 | $408K | Sell |
9,214
-6,344
| -41% | -$281K | 0.01% | 893 |
|
2022
Q2 | $759K | Buy |
15,558
+530
| +4% | +$25.9K | 0.03% | 633 |
|
2022
Q1 | $731K | Buy |
15,028
+354
| +2% | +$17.2K | 0.03% | 606 |
|
2021
Q4 | $626K | Sell |
14,674
-5,786
| -28% | -$247K | 0.04% | 551 |
|
2021
Q3 | $784K | Buy |
20,460
+9,272
| +83% | +$355K | 0.06% | 385 |
|
2021
Q2 | $316K | Buy |
+11,188
| New | +$316K | 0.03% | 687 |
|